3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
36
Colorectal Neoplasms
17
Small Cell Lung Carcinoma
8
Neoplasms
8
Stomach Neoplasms
7
Neoplasm Metastasis
5
Sarcoma, Ewing
4
Rhabdomyosarcoma
4
Recurrence
4
Osteosarcoma
4
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Ovarian Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Neuroblastoma
2
Nasopharyngeal Carcinoma
2
Metastatic Pancreatic Adenocarcinoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Somatostatinoma
1
Solid Tumor Cancer
1
Small Cell Lung Cancer Extensive Stage
1
Interventions
Exercise
10
Diet
5
Caloric Restriction
5
Nutrition Assessment
4
Metformin
4
Octreotide
3
Megestrol Acetate
3
Cognitive Behavioral Therapy
3
anamorelin
2
Standard of Care
2
Olanzapine
2
Mirtazapine
2
Melatonin
2
Liraglutide
2
Eicosapentaenoic Acid
2
Diet, Carbohydrate-Restricted
2
Diet Therapy
2
sibutramine
1
remune
1
olanzapine-fluoxetine combination
1
lime
1
irinotecan sucrosofate
1
bermekimab
1
Weight Reduction Programs
1
Tirzepatide
1
TOPS
1
Surveys and Questionnaires
1
Sugars
1
Sampling Studies
1
Ritonavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Weight Loss
×
irinotecan sucrosofate
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled